CI-966 is primarily researched for its potential applications in neuroscience, particularly as a cognitive enhancer. It has been studied for its ability to modulate neurotransmitter systems, which could be beneficial in treating cognitive disorders such as Alzheimer's disease and other forms of dementia. Additionally, CI-966 has shown promise in improving memory and learning capabilities in preclinical studies, making it a candidate for further investigation in the field of neuropharmacology. Its mechanism of action involves interacting with specific receptors in the brain, which may help in restoring cognitive functions impaired by neurological conditions.